← FDA Drug Approvals (Drugs@FDA)
ALOGLIPTIN
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MSN LABS PVT LTD · Approved 2019-01-29
Drug application
- FDA Application #
ANDA210213- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- ALOGLIPTIN
- Generic name
- Alogliptin Benzoate
- Active ingredients
- ALOGLIPTIN BENZOATE
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- None (Tentative Approval)
- Sponsor
- MSN LABS PVT LTD
- First approval
- 2019-01-29
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown